UI | ||||
---|---|---|---|---|
 | Yes n (%) n = 101 | No n (%) n = 31 | p value | OR (95% CI) |
Sex | Â | Â | Â | Â |
 Men | 14 (13.9) | 9 (29.0) |  | reference |
 Women | 87 (86.1) | 22 (71.0) | 0.051 | 2.54 (0.97-6.63) |
Primary school completed | ||||
 Yes | 48 (78.7) | 13 (21.3) |  | reference |
 No | 35 (92.1) | 3 (7.9) | 0.078 | 3.16 (0.83-11.93) |
Dementia | ||||
 No | 39 (66.1) | 20 (33.9) |  | reference |
 Yes | 60 (84.5) | 11 (15.5) | 0.014 | 2.79 (1.20–6.47) |
Stroke | ||||
 No | 76 (73.1) | 28 (26.9) |  | reference |
 Yes | 23 (88.5) | 3 (11.5) | 0.100 | 2.82 (0.78-10.14) |
Depression | ||||
 No | 67 (71.3) | 27 (28.7) |  | reference |
 Yes | 32 (88.9) | 4 (11.1) | 0.035 | 3.22 (1.04–9.99) |
Osteoarthritis | ||||
 No | 88 (78.6%) | 24 (21.4%) |  | reference |
 Yes | 11 (61.1%) | 7 (38.9%) | .136ª | 0.42 (0.15-1.22) |
Digestive disease | ||||
 No | 87 (80.6) | 21 (19.4) |  | reference |
 Yes | 12 (54.5 | 10 (45.5 | 0.014 | 0.29 (0.11-0.76) |
Group C drugs | ||||
 No | 49 (84.5) | 9 (15.5) |  | reference |
 1 or more | 51 (70.8) | 21 (29.2) | 0.066 | 0.44 (0.18-1.06) |
Group S drugs | ||||
 No | 97 (78.9) | 26 (21.1) |  | reference |
 1 or more | 3 (42.9) | 4 (21.1) | .049ª | 0.20 (0.42-0.95) |
Drugs to reduce micturition | ||||
 No | 8 (61.5) | 5 (38.5) |  | reference |
 1 or more | 92 (78.6) | 25 (21.4) | .176ª | 2.30 (0.69-7.64) |
Anticholinergic activity | ||||
 No | 30 (62.5) | 18 (37.5%) |  | reference |
 Yes (moderate-very high) | 70 (85.4) | 12 (14.6) | 0.005 | 3.50 (1.50–8.16) |
Falls last year | Â | Â | Â | Â |
 No | 51 (71.8) | 20 (28.2) |  | reference |
 Yes | 50 (82) | 1 (18.0) | 0.171 | 1.78 (0.77-4.09) |
Nocturia | ||||
 No | 55 (90.2) | 6 (9.8) |  | reference |
 Yes | 35 (71.4 | 14 (28.6) | 0.011 | 0.27 (0.09-0.77) |
Risk of sarcopenia (SARC-F) | ||||
 No | 18 (58.1) | 13 (41.9) |  | reference |
 Yes | 82 (82.0) | 18 (18.0) | 0.006 | 3.29 (1.36–7.90) |
Physical function (SPPB) | ||||
 Robust/Prefrailty/Frail | 26 (50) | 26 (50) |  | reference |
 Disability | 69 (94.5) | 4 (5.5) | < 0.001 | 17.25 (5.48–54.21) |
Mini Nutritional Assessment (MNA) | ||||
 Normal | 20 (64.5) | 11 (35.5) |  | reference |
 At risk– Malnourished | 66 (83.5) | 13 (16.5) | 0.030 | 2.7 (1.08–7.19) |
Cognitive capacity (Pfeiffer questionnaire) | ||||
 Normal/Slight | 24 (57.1) | 18 (42.9) |  | reference |
 Moderate/Severe | 77 (85.6) | 13 (14.4) | < 0.001 | 4.44 (1.90-10.37) |
ADL Limitations (Barthel) | ||||
 Independent/Slight dependency | 10 (37.0) | 17 (63.0) |  | reference |
 Moderate/Severe dependency | 91 (86.7) | 14 (13.3) | < 0.001 | 11.05 (4.22–28.93) |
Fecal Incontinence | ||||
 No | 63 (68.5) | 29 (31.5) |  | reference |
 Yes | 38 (95.0) | 2 (5.0) | < 0.001 | 8.74 (1.97–38.74) |